Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION.
Kato T, Yang JC, Ahn MJ, Sakai H, Morise M, Chen YM, Han JY, Yang JJ, Zhao J, Hsia TC, Berghoff K, Bruns R, Vioix H, Lang S, Johne A, Le X, Paik PK.
Kato T, et al. Among authors: ahn mj.
Br J Cancer. 2024 Apr 4. doi: 10.1038/s41416-024-02615-9. Online ahead of print.
Br J Cancer. 2024.
PMID: 38575731